Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices.
These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.
D000328:Adult; D000818:Animals; D000881:Anthrax / Q000276:immunology / Q000517:prevention & control*; D022122:Anthrax Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001408:Bacillus anthracis; D002648:Child; D006801:Humans; D007111:Immunity, Cellular; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D014481:United States
D022122:Anthrax Vaccines